Ovid Therapeutics Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Ovid Therapeutics Inc. (OVID) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $0 as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Investments
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2020-03-11
- 2019-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
- 2019-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
- 2019-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
- 2018-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $5.00M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months |
|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 |
| 2018-12-31 | $5.00M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |